Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
The American Society of Clinical Oncology Genitourinary Cancers Symposium, Moscone West Building, San Francisco, CA, USA, 7-9 January 2016 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, held in San Francisco (CA, USA), from 7 to 9 January 2016, focused on 'patient-centric care: translating research to results'. Every year, this meeting is a must for anyone studying genitourinary tumors to keep abreast of the most recent innovations in this field, exchange views on behaviors customarily adopted in daily clinical practice and discuss future topics of scientific research. This two-part report highlights the key themes presented at the 2016 ASCO Genitourinary Cancers Symposium, with part 1 reporting the main novelties of kidney cancer and part 2 discussing the most relevant issues which have emerged for bladder and prostate tumors.
Medical Oncology Unit, University Hospital of Parma, Italy.
Sebastiano
S
Buti
Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.
Chiara
C
Ciccarese
Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.
Roberto
R
Iacovelli
Medical Oncology Unit, University Hospital of Parma, Italy.
Melissa
M
Bersanelli
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, AOU Ospedali Riuniti, Ancona, Italy.
Marina
M
Scarpelli
Department of Surgery, Cordoba University Medical School, Cordoba, Spain.
Antonio
A
Lopez-Beltran
Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Liang
L
Cheng
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, AOU Ospedali Riuniti, Ancona, Italy.
Rodolfo
R
Montironi
Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.
Giampaolo
G
Tortora
Division of Oncology, S.Orsola-Malpighi Hospital, Bologna, Italy.
Francesco
F
Massari
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D000069473:Radiation Dose Hypofractionation; D012495:San Francisco; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents
biomarkers; genitourinary cancer; targeted therapy